MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Assessment of need for treatment with botulinum toxin type A in cervical dystonia patients

    C.L. Vaughan, G.T. Stebbins, C.L. Comella (Charleston, SC, USA)

    Objective: To prospectively assess the interval in weeks between injection of botulinum toxin A (BoNTA) and patient-perceived need for the next injection for treatment of…
  • 2016 International Congress

    Tourette syndrome and attention deficit hyperactivity disorders

    K. Aminov (Tashkent, Uzbekistan)

    Objective: Tourette syndrome (TS) and related tic disorders are commonly associated with obsessive-compulsive disorder (OCD) and attention deficit hyperactivity disorder (ADHD). It has been argued,…
  • 2016 International Congress

    Gender-dependent behavioral and biochemical differences in the A53T genetic mouse model of Parkinson’s disease

    G. Costa, M.J. Sisalli, L. Contu, A. Scorziello, M. Morelli (Cagliari, Italy)

    Objective: The main aim of the present study was to investigate whether behavioral and biochemical differences may occur between male and female old (12-month-old) transgenic…
  • 2016 International Congress

    Characterization of European longitudinal cohort studies in Parkinson’s disease – Report of the JPND working group BioLoC-PD

    S. Lerche, I. Liepelt-Scarfone, G. Alves, P. Barone, S. Behnke, Y. Ben-Shlomo, H. Berendse, D. Burn, R. Dodel, D. Grosset, M. Hu, M. Kasten, R. Krüger, W. Maetzler, B. Mollenhauer, W. Oertel, U. Walter, K. Wirdefeldt, D. Berg (Tübingen, Germany)

    Objective: To give an overview about ongoing European longitudinal studies investigating predictive and progression markers in Parkinson's disease (PD) to get an overview of the…
  • 2016 International Congress

    A cross-linguistic approach to speech intelligibility in people with PD

    Y. Kim, Y. Choi (Baton Rouge, LA, USA)

    Objective: The purpose is to compare acoustic models of speech intelligibility in individuals with the same disease (Parkinson's disease, PD) but with different native languages,…
  • 2016 International Congress

    The role of proprioceptive deficits as a mechanism of gait impairments in postural instability and gait disorder Parkinson’s disease subtype

    M.P. Pereira, P.H.S. Pelicioni, Q.J. Almeida, L.T.B. Gobbi (Leuven, Belgium)

    Objective: To evaluate the role of proprioceptive processing on the gait parameters of different subtypes of Parkinson's disease. Background: Two major subtypes are considered in…
  • 2016 International Congress

    Successful treatment of movement disorders after resection of midbrain cavernous malformations: Report of two cases

    A. Smolanka, V. Smolanka, K. Karpinska, M. Dovhanych, T. Havryliv (Uzhhorod, Ukraine)

    Objective: To evaluate the treatment of movement disorders which presented as a consequence of haemorrhage from midbrain cavernous malformations. Background: Few cases of movement disorders…
  • 2016 International Congress

    Biochemical features of lipids spectrum in blood in patients with Parkinson’s disease

    Z.A. Akbarkhodjaeva, F. Saidvaliev (Tashkent, Uzbekistan)

    Objective: To study characteristic of lipid levels in patients with PD. Background: Currently, there is no clear data about the features of lipid metabolism in…
  • 2016 International Congress

    Cognitive effects of AG-0029 in the chronic low-dose (CLD) 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson’s disease

    E.Y. Pioli, S.M.J. Camus, J. Yang, Q. Li, A. Crossman, E. Bezard, S. Hogg (Manchester, United Kingdom)

    Objective: To assess the cognitive functions in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaques following acute administration of AG-0029. Background: Parkinson's disease (PD), in which there is widespread degeneration…
  • 2016 International Congress

    Elemental profiles as biomarkers for diagnosis and disease progression of Parkinson’s disease

    F. Maass, M. Börger, A. Fischbach, B. Michalke, M. Bähr, I. Zerr, P. Lingor (Göttingen, Germany)

    Objective: This study aims to analyse the elemental profiles in the cerebrospinal fluid (CSF) of patients with idiopathic Parkinson´s disease (PD) and age-matched control patients…
  • « Previous Page
  • 1
  • …
  • 74
  • 75
  • 76
  • 77
  • 78
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Unusual prolonged survival in multiple system atrophy: A case report
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley